Where innovative Medical Go-To-Market Success is the rule! 

Want to Learn or See More? Click here

Synergistic Marketing, founded in 1990 by Mark Lutvak, is a successful, growing and profitable sales and marketing contracting firm and consultancy. We are dedicated to serving Small Emerging businesses that own or possess Medical Technology or Medical Device IP. We support our clients with a go-to-market strategy that takes advantage of our extensive network of medical industry companies as well as our extensive list of contacts who are our Corporate Partners.

Want to Learn or See More? Click here

 

Medical Technology and Device News Title

  • August 13, 2015:

    Scientists at MIT’s Koch Institute for Integrative Cancer Research have developed a tiny sensor that can provide doctor's onging data regarding a patient’s cancer to see how a therapy is working or a cancer is progressing. The sensor can be implanted in cancerous tissue during a biopsy. The sensor then measures predetermined biomarkers and wirelessly sends data to an external device, allowing physicians to adjust and monitor therapies accordingly.Full Story

  • August 4, 2015:

    Surgery, associated with cardiovascular diseases, such as ischemia, often require the implantation of vascular grafts to restore blood flow, but vascular grafts are susceptible to clot formation, which results in compulsory and lifelong intake of anticoagulants and additional surgery for some. The Journal of Medicinal Chemistry reports ITMO University scientists have developed artificial blood vessels that allow a drug-containing coating applied to the inner surface of the vessel that can dissolve clots.Full Story

  • July 23, 2015:

    Google, Novartis, and EPGL Race to Invent the First 'Autofocus' Contact Lens. A market  that could be worth, "anywhere between $10 billion and $50 billion in the next ten years." The Financial Times went on to say; " the company that offers its wearer 'autofocus'  similar to those found in digital cameras for bringing scenes into tight focus, will address a range of eye ailments and failings with a single solution, rather than requiring the kinds of fixed prescriptions that we use now, and that are often compromises rather than perfect solutions."Full Story

  • July 21, 2015:

    Glucose is consumed as an energy source by almost all life forms, from bacteria to human. The uptake of glucose by cells closely reflects their energetic needs, and is becoming poorly regulated in many pathological conditions such as obesity, diabetes and cancer. To visualize this important process, several prominent techniques have been developed in the past few decades. A new technique called stimulated Raman scattering (SRS) imaging is being used by labelling glucose with a small alkyne tag (i.e., carbon-carbon triple bond) to generate a strong and characteristic Raman scattering signal in the otherwise silent region, which can be picked up by SRS microscope with high sensitivity and specificity to produce a quantitative concentration map in three dimensions.Full Story

  • July 20, 2015:

    Scott Nyberg, M.D., Ph.D., principal investigator in the Artificial Liver and Liver Transplantation Laboratory at Mayo Clinic and his team have developed and are testing an alternative to liver transplantation called the Spheroid Reservoir Bioartificial Liver that can support healing and regeneration of the injured liver, and improve outcomes and reduce mortality rates for patients with acute liver failure — without requiring a transplant.Full Story

  • July 17, 2015:

    Transcranial magnetic stimulation significantly improved tinnitus symptoms in the largest U.S. clinical trial of its kind funded by the Veterans Affairs (VA) Rehabilitation Research and Development Service, researchers at the VA Portland Medical Center and Oregon Health & Science University.
    "For some study participants, this was the first time in years that they experienced any relief in symptoms. said Robert L. Folmer, Ph.D., research investigator with the National Center for Rehabilitative Auditory Research at the VA.Full Story